BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16791717)

  • 1. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain.
    Fornos JA; Andrés NF; Andrés JC; Guerra MM; Egea B
    Pharm World Sci; 2006 Apr; 28(2):65-72. PubMed ID: 16791717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil.
    Correr CJ; Melchiors AC; Fernandez-Llimos F; Pontarolo R
    Int J Clin Pharm; 2011 Apr; 33(2):273-80. PubMed ID: 21394570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study.
    Ali M; Schifano F; Robinson P; Phillips G; Doherty L; Melnick P; Laming L; Sinclair A; Dhillon S
    Diabet Med; 2012 Sep; 29(9):e326-33. PubMed ID: 22672148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.
    Pousinho S; Morgado M; Falcão A; Alves G
    J Manag Care Spec Pharm; 2016 May; 22(5):493-515. PubMed ID: 27123912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.
    Mehuys E; Van Bortel L; De Bolle L; Van Tongelen I; Annemans L; Remon JP; Giri M
    J Clin Pharm Ther; 2011 Oct; 36(5):602-13. PubMed ID: 21143256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of diabetes indices of care by a short pharmaceutical care program.
    Turnacilar M; Sancar M; Apikoglu-Rabus S; Hursitoglu M; Izzettin FV
    Pharm World Sci; 2009 Dec; 31(6):689-95. PubMed ID: 19777365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of diabetes education and short message service reminders on metabolic control and disease management in patients with type 2 diabetes mellitus.
    Güner TA; Coşansu G
    Prim Care Diabetes; 2020 Oct; 14(5):482-487. PubMed ID: 32471770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
    Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
    Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist-Managed Diabetes Center Interventions Ensure Quality and Safety in Elderly Patients.
    Twigg G; Motsko J; Thomas J; David T
    Consult Pharm; 2017 May; 32(5):299-310. PubMed ID: 28483010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus.
    Al Mazroui NR; Kamal MM; Ghabash NM; Yacout TA; Kole PL; McElnay JC
    Br J Clin Pharmacol; 2009 May; 67(5):547-57. PubMed ID: 19552750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
    Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
    Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial.
    Chen JH; Ou HT; Lin TC; Lai EC; Kao YH
    Int J Clin Pharm; 2016 Feb; 38(1):88-95. PubMed ID: 26499503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.
    Moretto TJ; Milton DR; Ridge TD; Macconell LA; Okerson T; Wolka AM; Brodows RG
    Clin Ther; 2008 Aug; 30(8):1448-60. PubMed ID: 18803987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 diabetes mellitus.
    Salinero-Fort MA; Carrillo-de Santa Pau E; Arrieta-Blanco FJ; Abanades-Herranz JC; Martín-Madrazo C; Rodés-Soldevila B; de Burgos-Lunar C
    BMC Public Health; 2011 Apr; 11():267. PubMed ID: 21524316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a community pharmacist-delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial.
    Jahangard-Rafsanjani Z; Sarayani A; Nosrati M; Saadat N; Rashidian A; Hadjibabaie M; Ashouri A; Radfar M; Javadi M; Gholami K
    Diabetes Educ; 2015 Feb; 41(1):127-35. PubMed ID: 25420946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of therapy with metformin plus pioglitazone in the treatment of patients with type 2 diabetes: a double-blind, placebo-controlled, clinical trial.
    Kaku K
    Curr Med Res Opin; 2009 May; 25(5):1111-9. PubMed ID: 19309251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia.
    Lim PC; Lim K; Embee ZC; Hassali MA; Thiagarajan A; Khan TM
    Pak J Pharm Sci; 2016 Mar; 29(2):595-601. PubMed ID: 27087103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.